Discovery of a Novel Compound Enhancing SVZ Neurogenic Effects via Human Neural Stem Cell-Based Phenotypic Screening

Atsushi Nakane1, Katsushi Kitahara1, Riku Fukushima1

  • 1Sumitomo Pharma Co., Ltd. 1-98, Kasugade-naka 3-chome, Konohana-ku, Osaka 554-0022, Japan.

Related Concept Videos